Yearly Review of Innovative Practice: December 2024 Edition
Dear subscribers,
Welcome to the December 2024 edition! Here we are at the end of 2024—how time flies! Reflecting on the past year, we are proud of the notable achievements and breakthroughs we've made. It brings us great joy to see how MGI's technologies and products have significantly impacted various fields worldwide.
This year also saw the establishment of new facilities, including our European headquarters and the CEC in Brazil. We take great pride in MGI’s achievements and look forward to reaching even greater heights together in the coming year.
Explore other highlights throughout December:
Yearly Review of Innovative Practice
As it's coming to the end of 2024, join us in reviewing the outcomes that MGI has achieved to benefit people worldwide through advanced life science technologies. MGI technologies and products have been profoundly engaged in various fields, including agriculture, environmental protection, and medical research.
Now let’s take a moment to reflect on MGI’s contributions to responding to global challenges.
We Drive Progress in Human Health Research: MGI Sequencing in Human Microbiome Study
At the Center for Microbial Translational Research, Karolinska Institutet, Prof. Engstrand has been working on scale-up microbiome research. With the high-throughput capacity of the DNBSEQ-T7 sequencer, his team is expanding sample sizes to gain deeper insights into microbial ecosystems. He believes the future lies in combining short reads and long reads, along with sequencing specific bacterial strains. This approach promises breakthroughs in single-cell and spatial transcriptomics, helping us understand microbial behavior like never before.
We Advocate for Sustainable Development and Ecological Protection: MGI Sequencing in Thai Mangrove Conservation
In Thailand, mangrove ecosystems are essential to the fishing industry and the general life of local people. However, over the past 50 years, over 60% of Thailand’s mangroves have been lost due to deforestation and urban development, highlighting the urgent need for conservation efforts.
A pioneering research team, led by Dr. Wirulda Pootakham at Thailand's National Omics Center (NOC) under BIOTEC-NSTDA is investigating the genetic diversity of Thai mangroves—a critical factor in prioritizing conservation strategies. Utilizing MGI sequencing, they have successfully obtained reference genomes for various Thai mangrove species, allowing for an accurate assessment of genetic diversity with high-quality DNA data.
We Promote Equity in Sports: MGI Sequencing First Applied in Anti-doping Research
Doping scandals have often marred the history of the Olympic Games, underscoring the urgent need for stronger anti-doping measures. This year, MGI is proud to support the anti-doping research led by Prof. Yannis Pitsiladis from Hong Kong Baptist University, a pioneer in this field and a key member of the International Olympic Committee Medical and Scientific Commission. He shared his exploration of using gene sequencing technology to bolster anti-doping efforts, bringing cutting-edge science to the forefront of the fight for fair play in sports.
We Dedicate Ourselves to Address Global Public Health Challenges: MGI Sequencing in HIV Elite Controllers Study
There were approximately 7.8 million people afflicted with HIV in South Africa, the highest absolute number of people living with HIV globally. Yet despite having the largest genetic diversity in the world, African human genome sequences represent the lowest of all the human genomes that have been sequenced worldwide.
"Elite controllers” (ECs) hold the key to curing HIV. For every 200 people living with HIV, around one may be an elite controller (0.5%). In South Africa, with its high rate of HIV infection, the prevalence of ECs also appears to be higher. By “unmasking” the secrets of ECs, researchers from the South African Medical Research Council (SAMRC) and the University of KwaZulu-Natal (UKZN) are revealing the answer to the natural control of HIV infection through DNBSEQ? technology, leading to improved health outcomes and quality of life amongst South Africans.
We Provide Innovative Solutions to Enhance Global Food Accessibility: MGI Low-Pass Sequencing Package Transforming Agricultural Genomics
Ensuring a future where everyone has access to safe and quality food relies on the advancement of agricultural technology. Although genome sequencing was introduced to aid in molecular breeding for agriculture, challenges remain, such as the high costs and data reliability associated with agricultural genome sequencing. MGI's Low-Pass Sequencing Package aims to address these issues, making it suitable for both large-scale and small-scale projects. This innovation is poised to bring transformative changes to the agricultural sector.
As a company committed to developing core tools and technologies that drive innovation in the life sciences, MGI is dedicated to making the world a better place through our cutting-edge technologies. Together, we strive to advance life sciences for a brighter future.
Advancing human genetics research in Peru: Interview with Dr. Ricardo Fujita
A recent interview from Instituto Nacional de Radio y Televisión del Perú - IRTP, Peru’s official government-run radio station, highlighted our collaboration with Universidad de San Martín de Porres! Learn how MGI is advancing human genetics research through the implementation of NGS technology from Dr Ricardo Fujita's talk.
领英推荐
Learn what makes MGI technologies and platforms special with Samantha Mendonsa
NGS has become an extremely powerful tool for modern research. However, challenges like data accuracy, platform versatility, and workflow optimization remain important for researchers. In this Q&A episode with Technology Networks, Samantha Mendonsa explores how MGI's innovative DNBSEQ technology and versatile platforms are redefining performance and simplifying workflows.
Discover the latest trends in spatial biology by reading the GEN ebook
The ebook <Spatiotemporal Omics: Advances to Integrate Multi-Omics Data> discusses some of the wide-ranging applications of spatial technology using examples that demonstrate the technology’s ability to provide a more fine-grained picture of cells’ underlying molecular mechanisms in areas such as digital pathology and developmental biology. Key takeaways include:
Join our DCS Grant Program in Hong Kong and Macao
Don't miss our DCS Grant Program in Hong Kong and Macao, designed to empower cutting-edge scientific research! Apply for FREE reagents to kickstart your spatial transcriptomics or single-cell research projects. This is a fantastic opportunity to advance your studies and contribute to pioneering discoveries!
Explore MGI's advanced technologies and products
Featuring one of the fastest sequencers in the world for mid-low throughput, the DNBSEQ-G99 can complete the sequencing of PE150 with Q40 data in just 12 hours. Join us for a demonstration by Mira to learn how to achieve flawless performance with the G99.
Troubled with contamination during library preparation? DNBelab-D4 is here to free you from the problem! Watch the video to discover MGI's advanced digital sample preparation platform, DNBelab-D4. Learn how this innovative platform can complete all library preparation steps automatically on a single cartridge in a fully enclosed manner.
Partnership with Sabin Group to improve health detection through genetic sequencing technology
MGI has recently partnered with Sabin Group, one of the largest diagnostic laboratories in Brazil, to improve health detection through genetic sequencing technology. This collaboration marks a major step forward in expanding Sabin's exam portfolio, giving Brazilians greater access to innovative genomics tests that could revolutionize healthcare and improve diagnostic accuracy.
Expanding Distribution Partnership in Italy with Euroclone SpA
Recently, MGI announced that Euroclone SpA, MGI's trusted distributor of MGI’s NGS sequencers and automation solutions in Italy, is now expanding its portfolio to include MGI’s customized automation solutions. This collaboration introduces advanced liquid handling solutions to the Italian market, going beyond NGS workflows to support applications in drug discovery, proteomics, pharma, and more.
Thank you for reading! Catch us next month and follow us on LinkedIn, X, and YouTube for more of the latest content from MGI. To get more information, please visit the MGI website.
Warmest regards,
The “MGI Newsletter” Editorial Team
Medical Devices | Healthcare Technology | Life Sciences | MBA
2 个月Great job from you guys at MGI. Happy New Year
--
2 个月Its about time that you better understood how our social system of macroeconomics really works, and not the pseudo-science version badly and incorrectly taught in most places! I can show you for free! write for a logical and true science 310-page explanation to: [email protected] and eliminate all you past confusion about it!